Antianginal treatment with azepine derivatives

US4259342A · kind A · utility

Assignee

• Boehringer Ingelheim GmbH · DE

Inventors

• Lothar Benedikter · Biberach an der Riß, DE
• Walter Kobinger · Wien, AT
• Ludwig Pichler · Wien, AT
• Hanns Ihrig · Biberach an der Riß, DE
• Gerhart Griss · Zell am Harmersbach, DE

Key dates

• Filing date: May 10, 1979
• Grant date: Mar 31, 1981
• Expiry date: May 10, 1999

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P9/10
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Antianginal pharmaceutical compositions containing as the active ingredient a compound of the formula ##STR1## wherein R.sub.1 is hydrogen, unsubstituted or hydroxyl-substituted alkyl of 1 to 4 carbon atoms; allyl; or unsubstituted or halo-, methyl-, methoxy- or trifluoromethyl-substituted benzyl; and PA1 X is oxygen or sulfur; or a non-toxic, pharmaceutically acceptable acid addition salt thereof; and methods of treating angina pectoris therewith.